From $24.44 million in 2020, the global Organ-On-Chip market is projected to reach $263.28 million by 2028. Based on our analysis the market is expected to grow at a CAGR of 34.6% from 2020 - 2028 timeframe.
Some of the prominent trends that the market is witnessing include technological advancements and new products launches, increasing focus on drug discovery activities, and growing initiatives to increase awareness about organs-on-chips technologies.
Global Organ-On-Chip Market: Market Dynamics
An organ-on-a-chip is a microfluidic cell culture tool that contains constantly perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the liver, heart, lung, gut, and other organs. Such devices create multiple levels of tissue and organ functionalities, which are not sufficient using conventional 2D and 3D culture systems. It offers a broad range of applications, such as patient stratification, disease modeling, and phenotypic screening.
Surge in applications of organ-on-chip (OOC) devices in the healthcare sector, nascent stage of R&D pertaining to OOCs, rise in in demand for OOCs for lung- & kidney-based organ culture, increase in demand for organ-on-chip in drug screening, high cost of OOC devices, and increase in research activities on OOC devices are the significant factors that impact the global organ-on-chip market growth.
On the other hand, issues pertaining to the incorporation of organ-on-chips technologies into the existing workflows are likely to obstruct the profit boundaries. In addition, growing focus on developing alternatives for animal testing models and growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers will further boost the organ-on-chip market.
Impact of COVID-19 on Organ-On-Chip
The outbreak of COVID-19 in the major economies of these regions such as the China and US, Japan has optimistically impacted the market growth. To control the spreading of COVID-19 among the world’s population the scientists and researchers have been using organ-on-chips for drug innovation for the vaccination and to understand immune responses against SARS-CoV-2. In Oct 2020, the Food and Drug Administration (FDA) had utilized organ-on-chip models to test mechanisms for preventing COVID-19 infections, and other processes. The FDA used Emulate Inc’s organ-on-chip models for this procedure under a cooperative research agreement. During the COVID-19 pandemic, the use of lung-on-chips was improved for the research and development of drugs to recover the lung infection caused by the virus. These factors affected the growth of the market positively.
Lung-On-Chip Segment Dominate the Market in 2020
The lung-on-chip segment made huge revenue in 2020 and growing its prominence during the forecast period. The lung-on-chip technology is a compound, three-dimensional model of a living, breathing human lung on a microchip. This device, prepared up of human lung and blood vessel cells, can expect the absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. With the arrangement of the microfabrication techniques, with modern tissue engineering, lung-on-chip also offers a new in vitro approach to drug screening by mimicking the complicated mechanical and biochemical behaviors of a human lung.
Asia Pacific Region is Leading in the Global Market Place
The Asia Pacific is likely to have a huge demand in the forecast period. The increase in disposable income of the population is expected to increase the adoption of organ-on-chip technology in the region. The government funding for regenerative medicines in research institutions, along with a growing number of cell-based clinical trials and investment in R&D activities, is estimated to increase the growth of the organ-on-chip market size in this region.
List of the Key Players Profiled in the Market Include:
List of the Regions/Countries Profiled in the Market Include:
North America • US • Canada • Mexico Europe • Germany • U.K • Italy • France • Spain • Rest of Europe Asia Pacific • China • Japan • India • Australia • New Zealand • Rest of Asia Pacific Middle East • Saudi Arabia • UAE • Rest of Middle East Latin America • Argentina • Brazil • Rest of Latin America Rest of the World (RoW) • South Africa • Others
Our reports have been used by over 10K customers, including:
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
The global apheresis equipment market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
129 pages •
By Global Industry Analysts
• Aug 2021
Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC and SLM Solutions Group AG. The global 3D printed implants market is expected to grow from $0.14 billion in 2020 to $0.15 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies...
Anatomic Pathology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology types, applications. Further, Anatomic Pathology...
Anatomic Pathology Track and Trace Solutions market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Track and Trace Solutions Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology...
Pathology Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pathology Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pathology Devices types, applications. Further, Pathology Devices...
The global arthroscopy devices market exhibited moderate growth during 2015-2020. Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body. They are primarily used for the treatment of medical conditions,...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.